Given that circUCK2(2,3) can induce TGFα-mediated EGFR activation, we then speculated that circUCK2(2,3) may, in turn, affect the response of HCC cells to EGFR inhibitors. The gene discussed is EGFR; the disease is hepatocellular carcinoma.